TBPH vs VTI
Theravance Biopharma Inc (TBPH) versus Vanguard Total Stock Market Index Fund ETF Shares (VTI) — a side-by-side from cached financials, not a winner call.
Theravance Biopharma Inc (TBPH) is a biotechnology company listed on NASDAQ.
Vanguard Total Stock Market Index Fund ETF Shares (VTI) common stock listed on US.
Latest reported TBPH revenue for 2026-06-30 was $38.4M. Net income was -$10.8M. TBPH currently screens at market cap $861.5M and trailing P/E 7.5.
VTI does not have a complete income-statement cache yet.
TBPH currently screens at market cap $861.5M and trailing P/E 7.5. VTI currently screens at market cap $0.
Not investment advice. Open the TBPH and VTI stock pages for the full models.
Not investment advice.